| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |